search
Back to results

IRAD2 : Patients With Respiratory Failure at Home

Primary Purpose

Chronic Respiratory Failure, Nutritional Depletion

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
education
Oral dietary supplements (563 kcal/d), RESPIFOR
exercises on an ergometric bicycle 3 to 5 times a week
160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women
Sponsored by
University Hospital, Grenoble
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Respiratory Failure focused on measuring Chronic Respiratory Failure, Pulmonary Rehabilitation, Nutritional Depletion, Home, COPD, Oral Dietary Supplements, Therapeutic Education, Androgens, Exacerbation, Survival

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: well informed and consenting person woman is old enough to procreate Assisted respiratory treatment at home for 3 months : oxygenotherapy > 8 hours per day and/or assisted ventilation > 6 hours per day. PaO2 without oxygenotherapy ≤ 8 kPa or 60 mmHg on ambient air at the beginning of assisted respiratory treatment. Affection : chronic obstructive bronchopneumopathy, diffuse bronchial dilatation, non neuromuscular restrictive syndrome (pulmonary diffuse infiltration, parietal lesion) obstructive and restrictive syndrome. malnourished person, one of following criteria :Body Mass Index ≤ 21kg/m2 or weight loss (10% of the previous weight) or non-fatty mass measured by 50 Hz impedancemetry ≤25th percentiles or ≤ 63% of ideal weight for women, ≤ 67% of ideal weight for men. Exclusion Criteria: Sleep apnea with daytime drowsiness (drowsiness scale of Epworth > 9/24) Known pathology that reduce the vital prognosis at 6 months (AIDS, cancer...). History of hormone dependent cancer ( breast cancer, prostate cancer), pathologic Prostate Specific Antigen. Inability to follow a rehabilitation program

Sites / Locations

  • University Hospital Dominique Larrey
  • Rehabilitation Department of Cyr Voisin
  • University Hospital Arnaud de Villeneuve
  • Hospital la Pitiè-Salpétrière
  • University Hospital of Poitiers
  • University Hospital Bois Guillaume
  • North University Hospital of St Etienne
  • Departement of Medicine, University Hospital of Genève

Outcomes

Primary Outcome Measures

An increase of the six-minute walking distance by more than 50 m with an improvement in health-related quality-of-life.

Secondary Outcome Measures

Reduction in exacerbation rates by 25%
Quality of life assessed by generic QOL.
Reduction in health-related costs
Increase in survival during the year following intervention.

Full Information

First Posted
September 30, 2005
Last Updated
July 7, 2009
Sponsor
University Hospital, Grenoble
Collaborators
Societe Francophone de Nutrition Enterale et Parenterale, Association ANTADIR ,, Ministry of Health, France, Association AGIR à Dom,, Nutricia France, swizerland),, Organon
search

1. Study Identification

Unique Protocol Identification Number
NCT00230984
Brief Title
IRAD2 : Patients With Respiratory Failure at Home
Official Title
Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2006
Overall Recruitment Status
Completed
Study Start Date
April 2003 (undefined)
Primary Completion Date
June 2008 (Actual)
Study Completion Date
June 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Grenoble
Collaborators
Societe Francophone de Nutrition Enterale et Parenterale, Association ANTADIR ,, Ministry of Health, France, Association AGIR à Dom,, Nutricia France, swizerland),, Organon

4. Oversight

5. Study Description

Brief Summary
Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion. This is a randomized controlled, open clinical trial with two groups. first group, 100 patients : control group, patients followed with no add-on intervention Second group, 100 patients : rehabilitation group with education, oral supplements, exercise and androgenic steroids.
Detailed Description
Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion State of the art : The IRAD2 trial is evaluating a 3-month home intervention which includes education, oral supplements, exercise and androgenic steroids in undernourished patients with chronic respiratory failure. The main objective is to increase the six-minute walking distance by more than 50 m with an improvement in health-related quality-of-life. Secondary end-points include a reduction in exacerbation rates by 25%, a reduction in health-related costs and an increase in survival during the year following intervention. Material and methods : This interventional, multi-centre, prospective, two-armed parallel, controlled trial is being conducted in 200 patients. In both groups, "Control" and "Rehabilitation", 7 home visits are scheduled during the 3-month intervention for education purpose. In the "Rehabilitation" group, patients will receive 160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women, oral dietary supplements (563 kcal/d) and exercises on an ergometric bicycle 3 to 5 times a week. Expected results : In the event of significant responses to intervention, this trial would validate a comprehensive and global home-care for undernourished patients with chronic respiratory failure combining therapeutic education, oral supplements, androgenic substitution and physical activity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Respiratory Failure, Nutritional Depletion
Keywords
Chronic Respiratory Failure, Pulmonary Rehabilitation, Nutritional Depletion, Home, COPD, Oral Dietary Supplements, Therapeutic Education, Androgens, Exacerbation, Survival

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
education
Intervention Type
Drug
Intervention Name(s)
Oral dietary supplements (563 kcal/d), RESPIFOR
Intervention Type
Behavioral
Intervention Name(s)
exercises on an ergometric bicycle 3 to 5 times a week
Intervention Type
Drug
Intervention Name(s)
160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women
Primary Outcome Measure Information:
Title
An increase of the six-minute walking distance by more than 50 m with an improvement in health-related quality-of-life.
Secondary Outcome Measure Information:
Title
Reduction in exacerbation rates by 25%
Title
Quality of life assessed by generic QOL.
Title
Reduction in health-related costs
Title
Increase in survival during the year following intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: well informed and consenting person woman is old enough to procreate Assisted respiratory treatment at home for 3 months : oxygenotherapy > 8 hours per day and/or assisted ventilation > 6 hours per day. PaO2 without oxygenotherapy ≤ 8 kPa or 60 mmHg on ambient air at the beginning of assisted respiratory treatment. Affection : chronic obstructive bronchopneumopathy, diffuse bronchial dilatation, non neuromuscular restrictive syndrome (pulmonary diffuse infiltration, parietal lesion) obstructive and restrictive syndrome. malnourished person, one of following criteria :Body Mass Index ≤ 21kg/m2 or weight loss (10% of the previous weight) or non-fatty mass measured by 50 Hz impedancemetry ≤25th percentiles or ≤ 63% of ideal weight for women, ≤ 67% of ideal weight for men. Exclusion Criteria: Sleep apnea with daytime drowsiness (drowsiness scale of Epworth > 9/24) Known pathology that reduce the vital prognosis at 6 months (AIDS, cancer...). History of hormone dependent cancer ( breast cancer, prostate cancer), pathologic Prostate Specific Antigen. Inability to follow a rehabilitation program
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christophe PISON, MD
Organizational Affiliation
Pneumology Department, University Hospital of Grenoble
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Dominique Larrey
City
Limoges
ZIP/Postal Code
87042
Country
France
Facility Name
Rehabilitation Department of Cyr Voisin
City
Loos
ZIP/Postal Code
59374
Country
France
Facility Name
University Hospital Arnaud de Villeneuve
City
Montpellier
ZIP/Postal Code
34295
Country
France
Facility Name
Hospital la Pitiè-Salpétrière
City
Paris
ZIP/Postal Code
75000
Country
France
Facility Name
University Hospital of Poitiers
City
Poitiers
ZIP/Postal Code
86021
Country
France
Facility Name
University Hospital Bois Guillaume
City
Rouen
ZIP/Postal Code
76230
Country
France
Facility Name
North University Hospital of St Etienne
City
St Etienne
ZIP/Postal Code
42055
Country
France
Facility Name
Departement of Medicine, University Hospital of Genève
City
Genève
ZIP/Postal Code
1211
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
9817145
Citation
Veale D, Chailleux E, Taytard A, Cardinaud JP. Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines. Eur Respir J. 1998 Oct;12(4):780-4. doi: 10.1183/09031936.98.12040780.
Results Reference
background
PubMed Identifier
5292850
Citation
Ronning O. Alterations in craniofacial morphogenesis induced by parenterally administered papain. An experimental study on the rat. Suom Hammaslaak Toim. 1971;67:Suppl 3:3-96. No abstract available.
Results Reference
background
PubMed Identifier
8617085
Citation
Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest. 1996 Mar;109(3):741-9. doi: 10.1378/chest.109.3.741.
Results Reference
background
PubMed Identifier
6110912
Citation
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981 Mar 28;1(8222):681-6.
Results Reference
background
PubMed Identifier
8947081
Citation
Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J. 1996 Nov;9(11):2335-9. doi: 10.1183/09031936.96.09112335.
Results Reference
background
PubMed Identifier
10556174
Citation
Barnes PJ. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S72-9. doi: 10.1164/ajrccm.160.supplement_1.17.
Results Reference
background
PubMed Identifier
6794394
Citation
Hunter AM, Carey MA, Larsh HW. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1981 Oct;124(4):376-81. doi: 10.1164/arrd.1981.124.4.376.
Results Reference
background
PubMed Identifier
8484624
Citation
Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993 May;147(5):1151-6. doi: 10.1164/ajrccm/147.5.1151.
Results Reference
background
PubMed Identifier
10741769
Citation
Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000 Mar;6(2):110-5. doi: 10.1097/00063198-200003000-00005.
Results Reference
background
PubMed Identifier
2595635
Citation
Schols AM, Mostert R, Soeters PB, Greve LH, Wouters EF. Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax. 1989 Nov;44(11):937-41. doi: 10.1136/thx.44.11.937.
Results Reference
background
PubMed Identifier
21700760
Citation
Pison CM, Cano NJ, Cherion C, Caron F, Court-Fortune I, Antonini MT, Gonzalez-Bermejo J, Meziane L, Molano LC, Janssens JP, Costes F, Wuyam B, Similowski T, Melloni B, Hayot M, Augustin J, Tardif C, Lejeune H, Roth H, Pichard C; IRAD Investigators. Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax. 2011 Nov;66(11):953-60. doi: 10.1136/thx.2010.154922. Epub 2011 Jun 23.
Results Reference
derived

Learn more about this trial

IRAD2 : Patients With Respiratory Failure at Home

We'll reach out to this number within 24 hrs